Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ŠPUNAROVÁ Michaela MALČÍKOVÁ Jitka TOM Nikola BORSKÝ Marek BRYCHTOVÁ Yvona DOUBEK Michael PANOVSKÁ Anna SKUHROVÁ FRANCOVÁ Hana ĎURECHOVÁ Kristina BRZOBOHATÁ A. FREIBERGEROVÁ Anna JAROŠOVÁ Marie MRÁZ Marek POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin

Year of publication 2018
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience, Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.